Transcriptional profiling of serogroup B Neisseria meningitidis growing in human blood: An approach to vaccine antigen discovery

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Hedman, Asa K ^a   Li, Ming Shi ^a   Langford, Paul R ^a   Kroll, J Simon ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; COMPLEMENT FACTOR H BINDING PROTEIN VACCINE; GLUTAMIC ACID; MENINGOCOCCUS VACCINE; NEISSERIAL SURFACE PROTEIN A VACCINE; PROTEINASE; PURINE; PYRIMIDINE; UNCLASSIFIED DRUG;

ADULT; AMINO ACID METABOLISM; AMINO ACID TRANSPORT; ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL STRAIN; COMPLEMENT SYSTEM; CONTROLLED STUDY; DOWN REGULATION; DRUG DETERMINATION; DRUG SYNTHESIS; ENERGY CONSERVATION; ENERGY METABOLISM; FLUORESCENCE ACTIVATED CELL SORTING; GENE FUNCTION; HOUSEKEEPING GENE; HUMAN; METABOLIC REGULATION; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEIC ACID SYNTHESIS; OPERON; SIALYLATION; TRANSCRIPTION REGULATION; UPREGULATION;

ADULT; FLOW CYTOMETRY; HUMANS; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS, SEROGROUP B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 84862663950     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039718     Document Type: Article

References (51)

1. Stephens DS, Greenwood B, Brandtzaeg P, (2007) Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369: 2196-2210.
2. Virji M, (2009) Pathogenic neisseriae: surface modulation, pathogenesis and infection control. Nat Rev Microbiol 7: 274-286.
3. Bentley SD, Vernikos GS, Snyder LA, Churcher C, Arrowsmith C, et al. (2007) Meningococcal genetic variation mechanisms viewed through comparative analysis of serogroup C strain FAM18. PLoS Genet 3: e23.
4. Parkhill J, Achtman M, James KD, Bentley SD, Churcher C, et al. (2000) Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature 404: 502-506.
5. Peng J, Yang L, Yang F, Yang J, Yan Y, et al. (2008) Characterization of ST-4821 complex, a unique Neisseria meningitidis clone. Genomics 91: 78-87.
6. Tettelin H, Saunders NJ, Heidelberg J, Jeffries AC, Nelson KE, et al. (2000) Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287: 1809-1815.
7. Sun YH, Bakshi S, Chalmers R, Tang CM, (2000) Functional genomics of Neisseria meningitidis pathogenesis. Nat Med 6: 1269-1273.
8. Goldschneider I, Gotschlich EC, Artenstein MS, (1969) Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 129: 1307-1326.
9. Ison CA, Anwar N, Cole MJ, Galassini R, Heyderman RS, et al. (1999) Assessment of immune response to meningococcal disease: comparison of a whole-blood assay and the serum bactericidal assay. Microb Pathog 27: 207-214.
10. Plested JS, Welsch JA, Granoff DM, (2009) Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity. Clin Vaccine Immunol 16: 785-791.
11. Kurz S, Hubner C, Aepinus C, Theiss S, Guckenberger M, et al. (2003) Transcriptome-based antigen identification for Neisseria meningitidis. Vaccine 21: 768-775.
12. Echenique-Rivera H, Muzzi A, Del Tordello E, Seib KL, Francois P, et al. (2011) Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival. PLoS Pathog 7: e1002027.
13. Ovstebo R, Brandtzaeg P, Brusletto B, Haug KB, Lande K, et al. (2004) Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J Clin Microbiol 42: 2980-2987.
14. Heist GD, Solis-Cohen S, Solis-Cohen M, (1922) A study of the virulence of Meningococci form man and of human susceptibility to meningococcic infection. J Immunol 7: 1-33.
15. Kerkhoven RM, Sie D, Nieuwland M, Heimerikx M, De Ronde J, et al. (2008) The T7-primer is a source of experimental bias and introduces variability between microarray platforms. PLoS One 3: e1980.
16. Friedrich T, Bottcher B, (2004) The gross structure of the respiratory complex I: a Lego System. Biochim Biophys Acta 1608: 1-9.
17. Kahler CM, Martin LE, Shih GC, Rahman MM, Carlson RW, et al. (1998) The (alpha2->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum. Infect Immun 66: 5939-5947.
18. Uria MJ, Zhang Q, Li Y, Chan A, Exley RM, et al. (2008) A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies. J Exp Med 205: 1423-1434.
19. Vogel U, Frosch M, (1999) Mechanisms of neisserial serum resistance. Mol Microbiol 32: 1133-1139.
20. Lewis LA, Ngampasutadol J, Wallace R, Reid JE, Vogel U, et al. (2010) The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement. PLoS Pathog 6: e1001027.
21. Schneider MC, Prosser BE, Caesar JJ, Kugelberg E, Li S, et al. (2009) Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 458: 890-893.
22. Leuzzi R, Serino L, Scarselli M, Savino S, Fontana MR, et al. (2005) Ng-MIP, a surface-exposed lipoprotein of Neisseria gonorrhoeae, has a peptidyl-prolyl cis/trans isomerase (PPIase) activity and is involved in persistence in macrophages. Mol Microbiol 58: 669-681.
23. Chen CY, Morse SA, (1999) Neisseria gonorrhoeae bacterioferritin: structural heterogeneity, involvement in iron storage and protection against oxidative stress. Microbiology 145 (Pt 10): 2967-2975.
24. Seib KL, Wu HJ, Srikhanta YN, Edwards JL, Falsetta ML, et al. (2007) Characterization of the OxyR regulon of Neisseria gonorrhoeae. Mol Microbiol 63: 54-68.
25. Monaco C, Tala A, Spinosa MR, Progida C, De Nitto E, et al. (2006) Identification of a meningococcal L-glutamate ABC transporter operon essential for growth in low-sodium environments. Infect Immun 74: 1725-1740.
26. Li MS, Chow NY, Sinha S, Halliwell D, Finney M, et al. (2009) A Neisseria meningitidis NMB1966 mutant is impaired for invasion of respiratory epithelial cells, survival in human blood and for virulence in vivo. Med Microbiol Immunol 198: 57-67.
27. Tala A, Monaco C, Nagorska K, Exley RM, Corbett A, et al. (2011) Glutamate utilization promotes meningococcal survival in vivo through avoidance of the neutrophil oxidative burst. Mol Microbiol 81: 1330-1342.
28. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
29. Pagliarulo C, Salvatore P, De Vitis LR, Colicchio R, Monaco C, et al. (2004) Regulation and differential expression of gdhA encoding NADP-specific glutamate dehydrogenase in Neisseria meningitidis clinical isolates. Mol Microbiol 51: 1757-1772.
30. Samant S, Lee H, Ghassemi M, Chen J, Cook JL, et al. (2008) Nucleotide biosynthesis is critical for growth of bacteria in human blood. PLoS Pathog 4: e37.
31. Ben-Zvi AP, Goloubinoff P, (2001) Review: mechanisms of disaggregation and refolding of stable protein aggregates by molecular chaperones. J Struct Biol 135: 84-93.
32. Grifantini R, Frigimelica E, Delany I, Bartolini E, Giovinazzi S, et al. (2004) Characterization of a novel Neisseria meningitidis Fur and iron-regulated operon required for protection from oxidative stress: utility of DNA microarray in the assignment of the biological role of hypothetical genes. Mol Microbiol 54: 962-979.
33. Giuliani MM, Adu-Bobie J, Comanducci M, Arico B, Savino S, et al. (2006) A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci U S A 103: 10834-10839.
34. Hung MC, Salim O, Williams JN, Heckels JE, Christodoulides M, (2011) The Neisseria meningitidis Macrophage Infectivity Potentiator Protein Induces Cross-Strain Serum Bactericidal Activity and Is a Potential Serogroup B Vaccine Candidate. Infect Immun 79: 3784-3791.
35. Keiser PB, Gibbs BT, Coster TS, Moran EE, Stoddard MB, et al. (2010) A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA. Vaccine 28: 6970-6976.
36. Joosten KF, de Kleijn ED, Westerterp M, de Hoog M, Eijck FC, et al. (2000) Endocrine and metabolic responses in children with meningoccocal sepsis: striking differences between survivors and nonsurvivors. J Clin Endocrinol Metab 85: 3746-3753.
37. Yu NY, Wagner JR, Laird MR, Melli G, Rey S, et al. (2010) PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 26: 1608-1615.
38. Picard F, Dressaire C, Girbal L, Cocaign-Bousquet M, (2009) Examination of post-transcriptional regulations in prokaryotes by integrative biology. C R Biol 332: 958-973.
39. Grifantini R, Bartolini E, Muzzi A, Draghi M, Frigimelica E, et al. (2002) Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays. Nat Biotechnol 20: 914-921.
40. Bartolini E, Frigimelica E, Giovinazzi S, Galli G, Shaik Y, et al. (2006) Role of FNR and FNR-regulated, sugar fermentation genes in Neisseria meningitidis infection. Mol Microbiol 60: 963-972.
41. Derrick JP, Urwin R, Suker J, Feavers IM, Maiden MC, (1999) Structural and evolutionary inference from molecular variation in Neisseria porins. Infect Immun 67: 2406-2413.
42. Gupta S, Maiden MC, Feavers IM, Nee S, May RM, et al. (1996) The maintenance of strain structure in populations of recombining infectious agents. Nat Med 2: 437-442.
43. O'Dwyer CA, Li MS, Langford PR, Kroll JS, (2009) Meningococcal biofilm growth on an abiotic surface - a model for epithelial colonization? Microbiology 155: 1940-1952.
44. Stabler RA, Marsden GL, Witney AA, Li Y, Bentley SD, et al. (2005) Identification of pathogen-specific genes through microarray analysis of pathogenic and commensal Neisseria species. Microbiology 151: 2907-2922.
45. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
46. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc, Ser B 57: 289-300.
47. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
48. Thompson JD, Higgins DG, Gibson TJ, (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
49. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, et al. (1999) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 27: 29-34.
50. Budroni S, Siena E, Hotopp JC, Seib KL, Serruto D, et al. (2011) Neisseria meningitidis is structured in clades associated with restriction modification systems that modulate homologous recombination. Proc Natl Acad Sci U S A 108: 4494-4499.
51. Joseph B, Schneiker-Bekel S, Schramm-Gluck A, Blom J, Claus H, et al. (2010) Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence. J Bacteriol 192: 5363-5377.